CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 9,480,052 shares at $2.15 ($20,382,112)
- 4 Open-market sale Vargeese Chandra sold 16,714 shares at $1.72 ($28,748)
- 4 Open-market sale President and CEO sold 33,501 shares at $1.72 ($57,622)
- 4 Open-market sale Chief Financial Officer sold 5,021 shares at $1.72 ($8,636)
- 4 Open-market sale Panzara Michael A. sold 16,714 shares at $1.72 ($28,748)
- 4 Open-market sale Francis Chris sold 10,867 shares at $1.72 ($18,691)
- 4 Open-market sale Chief Financial Officer sold 9,204 shares at $2.31 ($21,261)
- 4 Open-market sale Francis Chris sold 10,123 shares at $2.31 ($23,384)
- 4 Open-market sale Chief Technology Officer sold 10,603 shares at $2.32 ($24,599)
- 4 Open-market sale President and CEO sold 33,150 shares at $2.32 ($76,908)
Page 6 of 14 · 274 filings